Prospective, multicenter, open-label, observational study of sexual function in patients beginning aripiprazole treatment

被引：1
|
作者：
Montejo, A. L. [1 ]
Campos, M. C. [2 ]
Fombellida, C.
Franco, M.
Mellado, J. Garcia
Urnaiz, A. Perez [3 ]
Olivares, J. M. [4 ]
Ortega, M. A. [2 ]
Prieto, N. [1 ]
Riesgo, Y. [5 ]
Barber, I.
机构：
[1] Hosp Univ Salamanca, Salamanca, Spain
[2] Complejo Hosp San Millan, Logrono, Spain
[3] Hosp Meixoeiro, Vigo, Spain
[4] Bristol Myers Squibb Co, Dept Med, Madrid, Spain
[5] Otsuka Pharmaceut Co Ltd, Barcelona, Spain
来源：
EUROPEAN PSYCHIATRY | 2008年 / 23卷
关键词：
D O I：
10.1016/j.eurpsy.2008.01.846
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S133 / S134
页数：2
相关论文
共 50 条
  • [1] Observational, open-label, prospective multicenter study of sexual function in patients starting treatment with aripiprazole
    Montejo, A. L.
    Riesgo, Y.
    Luque, J.
    Barber, I.
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2010, 38 (01): : 13 - 21
  • [2] Augmentation of Aripiprazole for Depressed Patients With an Inadequate Response to Antidepressant Treatment: A 6-Week Prospective, Open-Label, Multicenter Study
    Jon, Duk-In
    Kim, Do Hoon
    Seo, Ho-Jun
    Kwon, Young-Joon
    Kim, Moon-Doo
    Yang, Jong-Chul
    Suh, Ho-Suk
    Min, Kyung Joon
    Pae, Chi-Un
    Bahk, Won-Myong
    CLINICAL NEUROPHARMACOLOGY, 2013, 36 (05) : 157 - 161
  • [3] A prospective open-label study of aripiprazole in fragile X syndrome
    Erickson, Craig A.
    Stigler, Kimberly A.
    Wink, Logan K.
    Mullett, Jennifer E.
    Kohn, Arlene
    Posey, David J.
    McDougle, Christopher J.
    PSYCHOPHARMACOLOGY, 2011, 216 (01) : 85 - 90
  • [4] A prospective open-label study of aripiprazole in fragile X syndrome
    Craig A. Erickson
    Kimberly A. Stigler
    Logan K. Wink
    Jennifer E. Mullett
    Arlene Kohn
    David J. Posey
    Christopher J. McDougle
    Psychopharmacology, 2011, 216 : 85 - 90
  • [5] A prospective, multicentre, open-label study to evaluate the effectiveness of aripiprazole in the treatment of a broad range of patients with schizophrenia
    Peuskens, J.
    Bervoets, C.
    Kok, F.
    Delatte, B.
    Touquet, G.
    Gillain, B.
    de Patoul, A.
    Halkin, V.
    Loze, J. -Y.
    Vansteelandt, K.
    Constant, E.
    EUROPEAN PSYCHIATRY, 2012, 27 (07) : 506 - 512
  • [6] Efficacy of quetiapine in patients with bipolar I and II depression: a multicenter, prospective, open-label, observational study
    Jeong, Jong-Hyun
    Bahk, Won-Myong
    Woo, Young Sup
    Seo, Ho-Jun
    Hong, Seung-Chul
    Jon, Duk-In
    Min, Kyung Joon
    Yoon, Bo-Hyun
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2013, 9 : 197 - 204
  • [7] Treatment of patients with keratoconjunctivitis sicca with Optive (TM) : results of a multicenter, open-label observational study in Germany
    Kaercher, Thomas
    Buchholz, Patricia
    Kimmich, Friedemann
    CLINICAL OPHTHALMOLOGY, 2009, 3 : 33 - 39
  • [8] Multicenter, prospective, open-label, observational study of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
    Pfennigsdorf, Stefan
    Ramez, Osman
    von Kistowski, Gerrit
    Maeder, Birgit
    Eschstruth, Peter
    Froboese, Michael
    Thelen, Ulrich
    Spraul, Christoph
    Schnober, Dietmar
    Cooper, Hazel
    Laube, Thomas
    CLINICAL OPHTHALMOLOGY, 2012, 6 : 739 - 746
  • [9] A prospective, open-label study of Aripiprazole mono- and adjunctive treatment in acute bipolar depression
    Dunn, Robert T.
    Stan, Vanessa A.
    Chriki, Lyvla S.
    Filkowski, Megan M.
    Ghaemi, S. Nassir
    JOURNAL OF AFFECTIVE DISORDERS, 2008, 110 (1-2) : 70 - 74
  • [10] An Open-Label Assessment of Aripiprazole in the Treatment of PTSD
    Robert, Sophie
    Hamner, Mark B.
    Durkalski, Valerie L.
    Brown, Mary W.
    Ulmer, Helen G.
    PSYCHOPHARMACOLOGY BULLETIN, 2009, 42 (01) : 69 - 80
12345